Yahoo Web Search

  1. You have a substantial retirement portfolio. If you did something similar, would it be advisable for you to trade your own retirement nest egg? It could be a good idea - that is, if you are ...

  2. Adobe- Changing the Digital World

    MoneyShow via Yahoo FinanceOct 09 10:00 AM

    Adobe's Digital Media segment, which represents 70% of the company's revenues and 90% of profits, delivered strong revenue growth in the quarter.

  3. Cramer Weighs In On Yeti, Square And More

    Benzinga via Yahoo FinanceOct 04 15:11 PM

    On CNBC's "Mad Money Lightning Round," Jim Cramer said he wants to buy Yeti Holdings Inc (NYSE: YETI). He is not worried about its balance sheet. Cramer wants to stay away from the commodity business.

  4. The first point is to adhere to the key principles of long-term investing, including developing a diversified portfolio that includes stocks with various styles, sizes, sectors and regions. Do You Know the Top 9 Retirement Investing Mistakes?

  5. Roche Announces Positive Late-Stage Data on Rituxan in PV

    Zacks via Yahoo FinanceOct 14 13:28 PM

    Roche RHHBY announced that the late-stage study, PEMPHIX, on its rheumatoid arthritis (RA) drug, MabThera/Rituxan for the indication of pemphigus vulgaris (PV) was successful. We note that Rituxan ...

  6. New Gilead CFO: Let's Make a Deal via Yahoo FinanceOct 18 15:22 PM

    GILD 30-Year Financial Data The intrinsic value of GILD Peter Lynch Chart of GILD Dickinson, who will retain responsibility for business development, masterminded Gilead's nearly $12 billion ...

  7. Fitbit in healthcare partnership to take on Apple Watch

    Reuters via Yahoo FinanceOct 17 15:15 PM

    Fitbit has been pushing deeper into the healthcare space and in August tied up with the Singapore government to provide fitness trackers and services in a health program that the company ...

  8. Humira to be overthrown as world's top-selling drug, report predicts

    Fox Business via Yahoo FinanceOct 07 20:41 PM

    Humira’s reign as the world's best-selling drug could soon come to an end. While the drug, manufactured by AbbVie and prescribed to treat Rheumatoid Arthritis, raked in nearly $20 billion in ...

  9. The KRAS G12C+ tumors present a $7-billion market opportunity, according to the company.

  10. Triple-B corporate borrowers find liquidity, safety in loans

    Reuters via Yahoo FinanceOct 10 19:03 PM

    US corporations hovering above junk territory are gravitating to the highly liquid bank market to fund acquisitions, and maintain their ratings and prepayment flexibility, while keeping market ...

  1. Ads